Risky behaviors and Parkinson’s disease: A Mendelian randomization study in up to 1 million study participants
Sandeep GroveriD, Greco M. Fabiola Del, Meike KasteniD, Christine KleiniD, Christina M. LilliD, Inke Regina KönigiD
Abstract
ObjectiveDopaminergic neurotransmission is known to be a potential modulator of risky behaviors including substance abuse, promiscuity, and gambling. Furthermore, observational studies have shown associations between risky behaviors and Parkinsons disease; however, the causal nature of these associations remains unclear. Thus, in this study, we examine causal associations between risky behavior phenotypes on Parkinsons disease using a Mendelian randomization approach.\n\nMethodsWe used two-sample Mendelian randomization to generate unconfounded estimates using summary statistics from two independent, large meta-analyses of genome-wide association studies on risk taking behaviors (n=370,771-939,908) and Parkinsons disease (cases: n=9581, controls: n = 33,245). We used inverse variance weighted as the main method for judging causality.\n\nResultsOur results support a strong protective association between the tendency to smoke and Parkinsons disease (OR=0.714 per log odds of ever smoking; 95% CI=0.568-0.897; p-value=0.0041; Cochran Q test; p-value=0.238; I2 index=6.3%). Furthermore, we observed risk association trends between automobile speed propensity as well as the number of sexual partners and Parkinsons disease after removal of overlapping loci with other risky traits (OR=1.986 for each standard deviation increase in normalized automobile speed propensity; 95% CI=1.215-3.243; p-value=0.0066, OR=1.635 for each standard deviation increase in number of sexual partners; 95% CI=1.165-2.293; p-value=0.0049).\n\nInterpretationThese findings provide support for a causal relationship between general risk tolerance and Parkinsons disease and may provide new insights in the pathogenic mechanisms leading to the development of Parkinsons disease.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 45
- FWCI
- 3.89
- Field percentile
- top 6%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Parkinsons Disease Mendelian Randomization Research Portal
Alastair John Noyce, Sara Bandrés‐Ciga, … Andrew Singleton·Movement DisordersPeer-reviewed·Oct 28, 2019
- Genetic and Proteomic Investigation of the Smoking-Parkinson Disease Association
Mingjian Shi, Tommy Gunawan, … Joshua C. Gray·medRxiv·Apr 20, 2026
- Dopamine replacement remediates risk aversion in Parkinson’s disease in a value-independent manner
Mariya V. Cherkasova, Jeffrey C. Corrow, … Jason J.S. Barton·Parkinsonism & Related DisordersPeer-reviewed·Aug 26, 2019
- A Mendelian randomization study of glycemic and anthropometric traits and Parkinson's disease
Sandeep Grover, Ricarda Graf, … Manu Sharma·bioRxiv·Mar 31, 2020
- Finding drug targeting mechanisms with genetic evidence for Parkinson's disease -- Mendelian randomization of the druggable genome
Catherine S. Storm, Demis A. Kia, … Nicholas William Wood·bioRxiv·Jul 24, 2020
- Dopamine Agonists in Parkinson's Disease Decouple Risk-Taking from Reward-Paired Cues by Enhancing Risky Choice in Their Absence
Katherine Muksuris, Ellen Flynn, … Mariya V. Cherkasova·bioRxiv·Sep 12, 2026